Skip to main content

Table 2 Positive selection at amino acid sites of cetacean TLR4

From: Adaptive evolution and functional constraint at TLR4 during the secondary aquatic adaptation and diversification of cetaceans

AA Positionsa

PAML Site Model (M8) p> 0.9

PAML Branch-Site Modelc

FELd p< 0.2

RELd BF > 50

AA Changes

Parallel Changes

Property Changese

Protein Domain

Functional Informationf

Cladeg

25

    

Ser-Arg

Yes

SM, P, NEU-P.POS

LRR3

 

B, C

28

  

0.07

 

Leu-Trp

 

NP, NEU-P, NEU

LRR3

 

A, D

     

Leu-Pro

 

NP, NEU-SM, NP, NEU

   

45

  

0.16

 

Thr-Ile

Yes

SM, P, NEU-NP, NEU

LRR4

 

A, F

104

  

0.17

 

Leu-Val

 

NP, NEU-NP, NEU

LRR6

  
     

Leu-Ser

 

NP, NEU-SM, P, NEU

   

128

 

0.875

  

Glu-Pro

 

P, NEG-SM, NP, NEU

LRR7

 

D

133

 

0.723

  

Asn-Lys

 

SM, P, NEU-P, POS

LRR7

 

G

139

 

0.708

  

Gly-Glu

 

SM, NP, NEU-P, NEG

LRR8

Adjacent to site involved in interaction with MD2

G

149

 

0.565

  

Ser/Leu -Thr

 

SM, P, NEU/NP, NEU -SM, P, NEU

LRR8

 

G

150

0.995

  

228.23

His-Arg

Yes

P, POS-P, POS

LRR8

 

A, B, C

     

His-Asp

 

P, POS-SM, P, NEG

   

177

   

61.94

Asn-Thr

Asn/Thr

-Ile

Asn-Lys

Ile-Asn

 

SM, P, NEU-SM, P, NEU

SM, P, NEU/SM, P, NEU

-NP, NEU

SM, P, NEU-P, POS

NP, NEU-SM, P, NEU

LRR9

Adjacent to site involved in ligand binding and interaction with MD2

A, C, G

179

0.992

 

0.07

647.96

Lys-Glu

Glu-Gln

Glu/Lys-

Gln

Yes

P, POS-P, NEG

P, NEG-P, NEU

P, NEG/P, POS-P, NEU

LRR9

 

A, C, F

183

  

0.12

51.06

Arg-Ser

Arg-Thr

 

P, POS-SM, P, NEU

P, POS-SM, P, NEU

LRR9

 

C, D

204

    

Glu-His

Yes

P, NEG-P, POS

LRR10

 

A, D

207

1.000

 

0.08

1563.58

Gly/Lys

-Arg

Arg-Lys

Arg-Thr

Lys-Arg

 

SM, NP, NEU/P, POS

-P, POS

P, POS-P, POSP,

POS-SM, P, NEU

P, POS-P, POS

LRR10

 

A, G, C, E

212

    

Leu-Val

Yes

P, POS-NP, NEU

LRR10

 

A, B

221

  

0.1

 

Val-Met

Yes

NP, NEU-NP, NEU

LRR11

 

C, D, F

228

0.994

 

0.15

544.88

Asp/Ser/Cys

-Asn

Asp-Asn

 

SM, P, NEG/SM, P, NEU/SM, NP, NEU

-SM, P, NEU

SM, P, NEG-SM, P, NEU

LRR11

 

A, G

230

0.978

   

Gly/Glu/Asp

-Arg

Asp-His

 

SM, NP, NEU/P, NEG/SM, P, NEG

-P.POS

SM, P, NEG-P, POS

LRR11

 

A, E

239

   

50.32

Cys-Tyr

Yes

SM, NP, NEU-P, NEU

LRR12

 

B, D, G

247

  

0.14

86.14

Ile-Thr

Thr-Ile

 

NP, NEU-SM, P, NEU

SM, P, NEU-NP, NEU

LRR12

Adjacent to site involved in interaction with ligand binding

C, G

250 b

0.936

   

Asp/Ala

-Lys

Asp/Lys/Ala

-Asn

Asn-Lys

 

SM, P, NEG/SM, NP, NEU

-P, POS

SM, P, NEG/P, POS/SM, NP, NEU

-SM, P, NEU

SM, P, NEU-P, POS

LRR12

Ligand binding

A, E, G

265

    

Phe-Leu

Yes

NP, NEU-NP, NEU

LRR13

 

B, E

272

0.997

 

0.13

188.28

Gly/Asp-

His

Gly-His

His-Gly

 

SM, NP, NEU/SM, P, NEG-P, POS

SM, NP, NEU-P, POS

P, POS-SM, NP, NEU

LRR13

Adjacent to site involved in interaction with ligand binding

A, C

280

0.952

 

0.18

191.07

Glu-Ala

Gln/Glu-

Ala

Yes

P, NEG-SM, NP, NEU

P, NEU/P, NEG-SM, NP, NEU

LRR13

 

A, B, E

302

 

0.624

  

His-Arg

 

P, POS-P.POS

LRR14

 

D

304

   

55.05

Asp-Asn

Asn-Pro

 

SM, P, NEG-SM, P, NEU

SM, P, NEU-SM, NP, NEU

LRR14

 

G

324

0.996

  

301.87

Asn-Ser

Asn-Lys

Gly-Asn

 

SM, P, NEU-SM, P, NEU

SM, P, NEU-P, POS

SM, NP, NEU-SM, P, NEU

LRR15

Adjacent to site involved in interaction with ligand binding (hydrogen bond)

C, E, G

342

   

53.56

Asn-Ser

Asn/Ser-

Thr

 

SM, P, NEU-SM, P, NEU

SM, P, NEU/SM, P, NEU-SM, P, NEU

LRR16

Adjacent to site involved in interaction with ligand binding (hydrogen bond)

A

351

   

0.17

Ile/Ala-Val

 

NP, NEU/SM, NP, NEU-NP, NEU

LRR16

Adjacent to site involved in interaction with ligand binding (hydrophobic interaction)

G

368

 

0.576

  

Ile-Thr

 

NP, NEU-SM, P, NEU

LRR17

Adjacent to site involved in interaction with ligand binding (hydrophobic interaction)

G

404

   

0.08

Leu-Met

 

NP, NEU-NP, NEU

LRR18

 

C

408

    

Ile-Thr

Yes

NP, NEU-SM, P, NEU

LRR19

 

A, G

409

   

0.19

Leu/Ile/Phe

-Val

 

NP, NEU/NP, NEU/NP, NEU

-NP, NEU

LRR19

 

A

482

   

0.16

Ser/Trp-

Phe

Phe/Ser/Trp

-Leu

 

SM, P, NEU/P, NEU-NP, NEU

NP, NEU/SM, P, NEU/P, NEU

-NP, NEU

LRR22

 

A

542

0.903

   

Met-Thr

Yes

NP, NEU-SM, P, NEU

LRRCT

 

A, D

551

0.938

   

Ile-Val

Val-Ile

Yes

NP, NEU-NP, NEU

NP, NEU-NP, NEU

Transmembrane

 

B, F

559

   

0.16

Val-Ala

 

NP, NEU-SM, NP, NEU

Transmembrane

 

G

690

 

0.564

  

Arg-Gln

 

P, POS-P, NEU

TIR

 

D

740

 

0.790

  

Glu-Asp

 

P, NEG-SM, P, NEG

TIR

 

G

742

 

0.697

  

Asn-Arg

 

SM, P, NEU-P, POS

TIR

 

G

743

   

0.18

Gln-Glu

 

P, NEU-P, NEG

TIR

 

A, F

  1. a Codons identified by more than one ML method were in bold and underlined.
  2. b Site 250 in italic was mapped onto the 3D structure of TLR4, since it directly participates in binding of LPS to TLR4.
  3. c Codons were identified by branch-site model in PAML. Details were in Materials and Methods and Additional file 2: Table S2.
  4. d Codons were estimated in DATAMONKEY.
  5. e SM, small; NP, nonpolar; P, polar; NEU, neutral; POS, positively charged; NEG, negatively charged.
  6. f Codons were in the functional regions predicted by the three-dimensional structure in Shishido et al. 2010. LRR = Leucine-rich repeat, CT = C-terminal, TIR = cytoplasmic Toll/IL-1 receptor
  7. g Amino acid substitutions occurred in the following clades: A = even-toed ungulates, B = river dolphins, C = oceanic dolpins, D = porpoises and white whales, E = sperm whales, F = baleen whales, G = more than one equally parsimonious reconstruction